Post reports legal action by CME against CFTC over perpetuals regulation. This is factual news reporting without the author expressing a directional view on CME's business or stock. No external data available to assess market reaction or context. Low confidence due to lack of author commentary on investment implications.
关键要点
CME leadership (Duffy) taking legal action against CFTC